1.01 USD
-0.05 (-4.72%)
Overall EVGN gets a fundamental rating of 2 out of 10. We evaluated EVGN against 525 industry peers in the Biotechnology industry. EVGN may be in some trouble as it scores bad on both profitability and health. EVGN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- EVGN had negative earnings in the past year.
- EVGN had a negative operating cash flow in the past year.
- EVGN had negative earnings in each of the past 5 years.
- EVGN had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -10.54%, EVGN belongs to the top of the industry, outperforming 83.81% of the companies in the same industry.
- EVGN has a worse Return On Equity (-240.72%) than 70.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.54% | ||
| ROE | -240.72% | ||
| ROIC | N/A |
ROA(3y)-45.19%
ROA(5y)-40.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- EVGN's Gross Margin of 50.19% is fine compared to the rest of the industry. EVGN outperforms 75.62% of its industry peers.
- In the last couple of years the Gross Margin of EVGN has declined.
- The Profit Margin and Operating Margin are not available for EVGN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.19% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-18.86%
2. Health
2.1 Basic Checks
- EVGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, EVGN has more shares outstanding
- Compared to 5 years ago, EVGN has less shares outstanding
- The debt/assets ratio for EVGN is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -15.41, we must say that EVGN is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -15.41, EVGN is doing worse than 80.00% of the companies in the same industry.
- EVGN has a Debt/Equity ratio of 1.62. This is a high value indicating a heavy dependency on external financing.
- The Debt to Equity ratio of EVGN (1.62) is worse than 77.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.62 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -15.41 |
ROIC/WACCN/A
WACC4.88%
2.3 Liquidity
- A Current Ratio of 5.11 indicates that EVGN has no problem at all paying its short term obligations.
- EVGN has a Current ratio of 5.11. This is comparable to the rest of the industry: EVGN outperforms 56.95% of its industry peers.
- A Quick Ratio of 4.59 indicates that EVGN has no problem at all paying its short term obligations.
- The Quick ratio of EVGN (4.59) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.11 | ||
| Quick Ratio | 4.59 |
3. Growth
3.1 Past
- EVGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 88.81%, which is quite impressive.
- Looking at the last year, EVGN shows a very negative growth in Revenue. The Revenue has decreased by -31.13% in the last year.
- EVGN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 62.55% yearly.
EPS 1Y (TTM)88.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.59%
Revenue 1Y (TTM)-31.13%
Revenue growth 3Y109.17%
Revenue growth 5Y62.55%
Sales Q2Q%-82.63%
3.2 Future
- The Earnings Per Share is expected to grow by 18.69% on average over the next years. This is quite good.
- EVGN is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -29.74% yearly.
EPS Next Y79.67%
EPS Next 2Y24.79%
EPS Next 3Y18.69%
EPS Next 5YN/A
Revenue Next Year-62.81%
Revenue Next 2Y-54.8%
Revenue Next 3Y-29.74%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- EVGN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year EVGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- EVGN's earnings are expected to grow with 18.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.79%
EPS Next 3Y18.69%
5. Dividend
5.1 Amount
- No dividends for EVGN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EVOGENE LTD / EVGN FAQ
Can you provide the ChartMill fundamental rating for EVOGENE LTD?
ChartMill assigns a fundamental rating of 2 / 10 to EVGN.
Can you provide the valuation status for EVOGENE LTD?
ChartMill assigns a valuation rating of 0 / 10 to EVOGENE LTD (EVGN). This can be considered as Overvalued.
How profitable is EVOGENE LTD (EVGN) stock?
EVOGENE LTD (EVGN) has a profitability rating of 1 / 10.
How financially healthy is EVOGENE LTD?
The financial health rating of EVOGENE LTD (EVGN) is 3 / 10.